All News

    Bringing Light to More Personalized Medicine in Lung Cancer After ASCO 2025

    June 12th 2025, 8:00pm

    Video

    Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.

    How Love Helped Me Overcome my Cancer Diagnosis

    June 12th 2025, 7:00pm

    Article

    Facing two life-threatening diagnoses, I overcame fear of self-injections by leaning on love, encouragement and determination to save my life.

    FDA Approves UGN-102 For Some With Bladder Cancer

    June 12th 2025, 6:11pm

    Article

    The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder cancer.

    Don’t Miss Your Shot: A Letter to My Newly Diagnosed Self

    June 12th 2025, 5:00pm

    Article

    Eminem’s lyric about having “one shot” stayed with me, and writing this letter to my newly diagnosed self, reminds me how that mindset saved my life.

    What Patients With Genitourinary Cancers Need to Know After ASCO 2025

    June 12th 2025, 4:00pm

    Article

    Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.

    FDA Approves Brukinsa Tablet For Various Blood Cancers

    June 12th 2025, 3:00pm

    Article

    FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as capsules.

    A New Therapeutic Approach May Make Waves in Kidney Cancer Treatment

    June 12th 2025, 1:00pm

    Video

    Dr. Michael Serzan provides expert takeaways on treatment updates for patients with early-stage kidney cancer following the 2025 ASCO Meeting.

    Being a Cancer Survivor is a Gift I Never Take for Granted

    June 11th 2025, 9:00pm

    Article

    Being a cancer survivor for nine and a half years has taught me to live in the moment, to make those moments count.

    What Patients With Genitourinary Cancers Should Know After ASCO 2025

    June 11th 2025, 8:00pm

    Video

    Dr. Joshua K. Sabari sat down with Dr. Daniel V. Araujo to discuss topline takeaways from the 2025 ASCO Meeting across the realm of genitourinary oncology

    FDA Approves Ibtrozi for ROS1+ Advanced Non-Small Cell Lung Cancer

    June 11th 2025, 5:40pm

    Article

    The U.S. FDA has approved treatment with Ibtrozi for patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.